Intestinal Lactobacillus in health and disease, a driver or just along for the ride?

Current Opinion in Biotechnology

Volumn 49, Issue , 2018, Pages 140-147

  Heeney, Dustin D ^a   Gareau, Mélanie G ^b   Marco, Maria L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY;

CHRONIC CONDITIONS; COLONIC MICROBIOTA; FOOD FERMENTATION; HUMAN DISEASE; HUMAN HEALTH; HUMAN MICROBIOME; LACTOBACILLUS SPECIES; METAGENOMICS;

ANIMALS;

PROBIOTIC AGENT; RNA 16S;

AUTOIMMUNITY; BEHAVIOR DISORDER; COGNITIVE DEFECT; GASTROINTESTINAL TRACT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS; MALIGNANT NEOPLASM; META ANALYSIS (TOPIC); MICROBIAL DIVERSITY; MICROBIOME; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DEVELOPMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; SIMIAN IMMUNODEFICIENCY VIRUS; SYSTEMATIC REVIEW (TOPIC); ANIMAL; BEHAVIOR; BIODIVERSITY; COGNITION; DISEASES; HEALTH; INTESTINE; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; BEHAVIOR; BIODIVERSITY; COGNITION; DISEASE; HEALTH; HUMANS; INTESTINES; LACTOBACILLUS;

EID: 85028696126     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2017.08.004     Document Type: Review

References (64)

1. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11 (2014), 506–514.
2. Marco, M.L., Heeney, D., Binda, S., Cifelli, C.J., Cotter, P.D., Foligné, B., Gänzle, M., Kort, R., Pasin, G., Pihlanto, A., et al. Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol 44 (2017), 94–102.
3. Floch, M.H., Walker, W.A., Sanders, E., Nieuwdorp, M., Kim, A.S., Brenner, D.A., Qamar, A.A., Miloh, T.A., Guarino, A., Guslandi, M., et al. Recommendations for probiotic use — 2015 update proceedings and consensus opinion. J Clin Gastroenterol 49 (2015), S69–S73.
4. Almonacid, D.E., Kraal, L., Ossandon, F.J., Budovskaya, Y.V., Cardenas, J.P., Bik, E.M., Goddard, A.D., Richman, J., Apte, Z.S., 16S rRNA gene sequencing and healthy reference ranges for 28 clinically relevant microbial taxa from the human gut microbiome. PLOS ONE 12 (2017), 1–15.
5. Chu, D.M., Ma, J., Prince, A.L., Antony, K.M., Seferovic, M.D., Aagaard, K.M., Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med 23 (2017), 314–323.
6. Nistal, E., Caminero, A., Herran, A.R., Perez-Andres, J., Vivas, S., Ruiz De Morales, J.M., Saenz de Miera, L.E., Casqueiro, J., Study of duodenal bacterial communities by 16S rRNA gene analysis in adults with active celiac disease vs non-celiac disease controls. J Appl Microbiol 120 (2015), 1691–1700.
7. Fan, P., Liu, P., Song, P., Chen, X., Ma, X., Moderate dietary protein restriction alters the composition of gut microbiota and improves ileal barrier function in adult pig model. Sci Rep 7 (2017), 1–12.
8. Slifierz, M.J., Friendship, R.M., Weese, J.S., Longitudinal study of the early-life fecal and nasal microbiotas of the domestic pig. BMC Microbiol 15 (2015), 1–12.
9. Mohan, M., Chow, C.E.T., Ryan, C.N., Chan, L.S., Dufour, J., Aye, P.P., Blanchard, J., Moehs, C.P., Sestak, K., Dietary gluten-induced gut dysbiosis is accompanied by selective upregulation of microRNAs with intestinal tight junction and bacteria-binding motifs in rhesus macaque model of celiac disease. Nutrients 8 (2016), 1–18.
10. Li, D., Chen, H., Mao, B., Yang, Q., Zhao, J., Gu, Z., Zhang, H., Chen, Y.Q., Chen, W., Microbial biogeography and core microbiota of the rat digestive tract. Sci Rep 7 (2017), 1–16.
11. Morikawa, M., Tsujibe, S., Kiyoshima-Shibata, J., Watanabe, Y., Kato-Nagaoka, N., Shida, K., Matsumoto, S., Microbiota of the small intestine is selectively engulfed by phagocytes of the lamina propria and Peyer's patches. PLOS ONE 11 (2016), 1–16.
12. 8 cells/g in the stool of a human subject. Metagenomics enabled the identification of strain-level distinctions among the lactobacilli and individual Lactobacillus genotypes were consistently detected in the stool over a time span of nearly two years.
13. + T cells compared to women with diverse genital bacterial communities. The results were supported by the lower numbers of activated CD4+ T cells in the genital mucosa of germ-free mice intravaginally-inoculated with L. crispatus compared with HIV-associated bacterial taxa.
14. Duar, R.M., Frese, S.A., Fernando, S.C., Burkey, T.E., Tasseva, G., Peterson, D.A., Blom, J., Wenzel, C.Q., Szymanski, C.M., Walter, J., Experimental determination of host adaptation of Lactobacillus reuteri to different vertebrate species. Appl Environ Microbiol 83 (2017), 1–44.
15. Yang, L., Poles, M.A., Fisch, G.S., Ma, Y., Nossa, C., Phelan, J.A., Pei, Z., HIV-induced immunosuppression is associated with colonization of the proximal gut by environmental bacteria. AIDS 30 (2016), 19–29.
16. Vujkovic-Cvijin, I., Swainson, L.A., Chu, S.N., Ortiz, A.M., Santee, C.A., Petriello, A., Dunham, R.M., Fadrosh, D.W., Lin, D.L., Faruqi, A.A., et al. Gut-resident Lactobacillus abundance associates with IDO1 inhibition and Th17 dynamics in SIV-infected macaques. Cell Rep 13 (2015), 1589–1597.
17. Hirao, L.A., Grishina, I., Bourry, O., Hu, W.K., Somrit, M., Sankaran-Walters, S., Gaulke, C.A., Fenton, A.N., Li, J.A., Crawford, R.W., et al. Early mucosal sensing of SIV infection by paneth cells induces IL-1beta production and initiates gut epithelial disruption. PLoS Pathog 10 (2014), 1–15.
18. Golomb, B.L., Hirao, L.A., Dandekar, S., Marco, M.L., Gene expression of Lactobacillus plantarum and the commensal microbiota in the ileum of healthy and early SIV-infected rhesus macaques. Sci Rep 6 (2016), 1–10.
19. d'Ettorre, G., Rossi, G., Scagnolari, C., Andreotti, M., Giustini, N., Serafino, S., Schietroma, I., Scheri, G.C., Fard, S.N., Trinchieri, V., et al. Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients. Immunity Inflamm Dis, 2017, 10.1002/iid3.160.
20. Zelante, T., Iannitti, R.G., Cunha, C., DeLuca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D'Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39 (2013), 372–385 This early report singled out intestinal and vaginal lactobacilli for a potent ability to produce tryptophan metabolites that activate host-AHRs in epithelium tissue. The activation of epithelial AHRs induces the production of a myriad of antimicrobial compounds and was found to be essential for control of opportunistic pathogens. Importantly, AHR knockout mice infected with Candida albicans could not be rescued by introduction of tryptophan-metabolizing lactobacilli.
21. Kamdar, K., Khakpour, S., Chen, J., Leone, V., Brulc, J., Mangatu, T., Antonopoulos, D.A., Chang, E.B., Kahn, S.A., Kirschner, B.S., et al. Genetic and metabolic signals during acute enteric bacterial infection alter the microbiota and drive progression to chronic inflammatory disease. Cell Host Microbe 19 (2016), 21–31 In TLR1 knockout mice the acute intestinal infection of Yersinia enterocolitica destabilizes mucosal immunity allowing blooms of δ-Proteobacteria and diminished levels of other taxa, including lactobacilli. Chronic immune responses against the commensal microbiota were observed two months postinfection. Supplementation with L. reuteri was sufficient to revert the immune system towards homeostasis.
22. da Fonseca, D.M., Hand, T.W., Han, S-J., Gerner, M.Y., Zaretsky, A.G., Byrd, A.L., Harrison, O.J., Ortiz, A.M., Quinones, M., Trinchieri, G., et al. Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity. Cell 163 (2017), 354–366.
23. Liu, H-N., Wu, H., Chen, Y-Z., Chen, Y-J., Shen, X-Z., Liu, T-T., Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: a systematic review and meta-analysis. Dig Liver Dis 49 (2017), 331–337.
24. Zhuang, X., Xiong, L., Li, L., Li, M., Chen, M., Alterations of gut microbiota in patients with irritable bowel syndrome: a systematic review and meta-analysis. J Gastroenterol Hepatol 32 (2017), 28–38.
25. Ford, A.C., Quigley, E.M.M., Lacy, B.E., Lembo, A.J., Saito, Y.A., Schiller, L.R., Soffer, E.E., Spiegel, B.M.R., Moayyedi, P., Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 109 (2014), 1547–1561.
26. Lewis, J.D., Chen, E.Z., Baldassano, R.N., Otley, A.R., Griffiths, A.M., Lee, D., Bittinger, K., Bailey, A., Friedman, E.S., Hoffmann, C., et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe 18 (2015), 489–500.
27. Wang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., Wang, G., Xia, B., Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol 52 (2014), 398–406.
28. Ganji-Arjenaki, M., Rafieian-Kopaei, M., Probiotics are a good choice in remission of inflammatory bowel diseases: a meta-analysis and systematic review. J Cell Physiol, 2017, 10.1002/jcp.25911.
29. Lamas, B., Richard, M.L., Leducq, V., Pham, H-P., Michel, M-L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T.W., Natividad, J.M., et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med 22 (2016), 598–605 Human single nucleotide polymorphism (SNP) studies indicate caspase recruitment domain family member 9 (CARD9) alleles are associated with inflammatory bowel disease and that this risk allele may influence the development of a pro-inflammatory microbiome. By using CARD9 knockout mice, this report links CARD9 deficiencies to an altered intestinal microbiome with reduced production of AHR ligands. L. reuteri was identified as a significantly depleted taxon and replenishment of this species improved symptoms of colitis in CARD9 knockout mice.
30. Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., Wu, X., Li, J., Tang, L., Li, Y., et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 21 (2015), 895–905 This human study utilizing metagenomic sequencing on the fecal microbiota identified several species of intestinal Lactobacillus species that were elevated in the oral and fecal microbiota of RA patients compared with healthy subjects.
31. Liu, X., Zeng, B., Zhang, J., Li, W., Mou, F., Wang, H., Zou, Q., Zhong, B., Wu, L., Wei, H., et al. Role of the gut microbiome in modulating arthritis progression in mice. Sci Rep 6 (2016), 1–11.
32. Vaghef-Mehrabany, E., Alipour, B., Homayouni-Rad, A., Sharif, S-K., Asghari-Jafarabadi, M., Zavvari, S., Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition 30 (2014), 430–435.
33. Zamani, B., Golkar, H.R., Farshbar, S., Emadi-Baygi, M., Tajabadi-Ebrahimi, M., Jafari, P., Akhavan, R., Taghizadeh, M., Memarzadeh, M.R., Asemi, Z., Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Int J Rheum Dis 19 (2016), 869–879.
34. Alkanani, A.K., Hara, N., Gottlieb, P.A., Ir, D., Robertson, C.E., Wagner, B.D., Frank, D.N., Zipris, D., Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes 64 (2015), 3510–3520 In this cohort study, the genetic component of T1D was partially controlled for by recruiting T1D patients and their healthy, first-degree relatives. The fecal microbiota was assessed by 16S rRNA sequencing as an environmental factor associated with disease. Lactobacillus proportions were significantly depleted in T1D patients.
35. de Goffau, M.C., Fuentes, S., Van Den Bogert, B., Honkanen, H., De Vos, W.M., Welling, G.W., Hyöty, H., Harmsen, H.J.M., Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 57 (2014), 1569–1577.
36. Uusitalo, U., Liu, X., Yang, J., Hummel, S., Butterworth, M., Rewers, M., Hagopian, W., She, J., Simell, O., Toppari, J., et al. Association of early exposure of probiotics and islet autimmunity in the TEDDY study. JAMA Pediatr 170 (2016), 20–28.
37. Chen, J., Chia, N., Kalari, K.R., Yao, J.Z., Novotna, M., Soldan, M.M.P., Luckey, D.H., Marietta, E.V., Jeraldo, P.R., Chen, X., et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep 6 (2016), 1–10.
38. Stanisavlijević, S., Lukić, J., Soković, S., Mihajlović, S., Stojković, M.M., Miljković, D., Golić, N., Correlation of gut microbiota composition with resistance to experimental autoimmune encephalomyelitis in rats. Front Microbiol 7 (2016), 1–12.
39. Kouchaki, E., Tamtaji, O.R., Salami, M., Bahmani, F., Daneshvar Kakhaki, R., Akbari, E., Tajabadi-Ebrahimi, M., Jafari, P., Asemi, Z., Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clin Nutr, 2016, 10.1016/j.clnu.2016.08.015.
40. Lim, C.K., Bilgin, A., Lovejoy, D.B., Tan, V., Bustamante, S., Taylor, B.V., Bessede, A., Brew, B.J., Guillemin, G.J., Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression. Sci Rep 7 (2017), 1–9.
41. Rothhammer, V., Mascanfroni, I., Bunse, L., Takenaka, M., Kenison, J., Mayo, L., Chao, C-C., Patel, B., Yan, R., Blain, M., et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 22 (2016), 586–597 This mouse study causally links lactobacilli to the production of AHR ligands and mitigation of experimentally induced central nervous system inflammation. Reconstitution of an antibiotic-disrupted microbiome with L. reteuri capable of metabolizing tryptophan was sufficient to improve markers of disease.
42. Ignacio, A., Fernandes, M.R., Rodrigues, V.A.A., Groppo, F.C., Cardoso, A.L., Avila-Campos, M.J., Nakano, V., Correlation between body mass index and faecal microbiota from children. Clin Microbiol Infect 22 (2016), 1–8.
43. Riva, A., Borgo, F., Lassandro, C., Verduci, E., Morace, G., Borghi, E., Berry, D., Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Fiirmicutes populations. Environ Microbiol 19 (2017), 95–105.
44. Hu, H.J., Park, S.G., Jang, H.B., Choi, M.G., Park, K.H., Kang, J.H., Park, S.I., Lee, H.J., Cho, S.H., Obesity alters the microbial community profile in Korean Adolescents. PLOS ONE 10 (2015), 1–14.
45. Teixeira, T.F.S., Grześkowiak ŁM, Salminen, S., Laitinen, K., Bressan, J., Gouveia Peluzio, M., do, C., Faecal levels of Bifidobacterium and Clostridium coccoides but not plasma lipopolysaccharide are inversely related to insulin and HOMA index in women. Clin Nutr 32 (2013), 1017–1022.
46. Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C.J., Fagerberg, B., Nielsen, J., Bäckhed, F., Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (2013), 99–103.
47. Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., Krogh Pedersen, H., et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528 (2015), 262–266.
48. Sáez-Lara, M.J., Robles-Sanchez, C., Ruiz-Ojeda, F.J., Plaza-Diaz, J., Gil, A., Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials. Int J Mol Sci 17 (2016), 1–15.
49. Drissi, F., Raoult, D., Merhej, V., Metabolic role of lactobacilli in weight modification in humans and animals. Microb Pathog, 2016, 10.1016/j.micpath.2016.03.006.
50. Le Roy, C.I., Štšepetova, J., Sepp, E., Songisepp, E., Sandrine, P., Mikelsaar, M., New insights into the impact of Lactobacillus population on host-bacteria metabolic interplay. Oncotarget 6 (2015), 30545–30556.
51. Gonzalez, F.J., Jiang, C., Patterson, A.D., An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease. Gastroenterology 151 (2016), 845–859.
52. Zhang, L., Xie, C., Nichols, R.G., Chan, S.H.J., Jiang, C., Hao, R., Smith, P.B., Cai, J., Simons, M.N., Hatzakis, E., et al. Farnesoid X receptor signaling shapes the gut microbiota and controls hepatic lipid metabolism. mSystems 1 (2016), 1–17.
53. Borges-Canha, M., Portela-Cidade, J.P., Dinis-Ribeiro, M., Leite-Moreira, A.F., Pimentel-Nunes, P., Role of colonic microbiota in colorectal carcinogenesis: a systematic review. Rev Esp Enferm Dig 107 (2015), 659–671.
54. Li, J., Sung, C.Y.J., Lee, N., Ni, Y., Pihlajamäki, J., Panagiotou, G., El-Nezami, H., Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci U S A 113 (2016), E1306–E1315.
55. Hieken, T.J., Chen, J., Hoskin, T.L., Walther-Antonio, M., Johnson, S., Ramaker, S., Xiao, J., Radisky, D.C., Knutson, K.L., Kalari, K.R., et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep 6 (2016), 1–10.
56. Guerrero-Preston, R., Godoy-Vitorino, F., Jedlicka, A., Rodríguez-Hilario, A., González, H., Bondy, J., Lawson, F., Folawiyo, O., Michailidi, C., Dziedzic, A., et al. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papillomavirus infection and surgical treatment. Oncotarget 7 (2016), 51320–51334.
57. Zijlmans, M.A.C., Korpela, K., Riksen-Walraven, J.M., de Vos, W.M., de Weerth, C., Maternal prenatal stress is associated with the infant intestinal microbiota. Psychoneuroendocrinology 53 (2015), 233–245 16S rRNA sequencing of fecal microbiomes from a mother–infant cohort before and after birth allowed Zijlmans and colleagues to link maternal prenatal stress to alterations in the infant microbiome. Pathobionts were enriched in infants whose mothers were more stressed. Lactobacillus cell numbers were depleted.
58. Golubeva, A.V., Crampton, S., Desbonnet, L., Edge, D., O'Sullivan, O., Lomasney, K.W., Zhdanov, A.V., Crispie, F., Moloney, R.D., Borre, Y.E., et al. Prenatal stress-induced alterations in major physiological systems correlate with gut microbiota composition in adulthood. Psychoneuroendocrinology 60 (2015), 58–74.
59. Leclercq, S., Mian, F.M., Stanisz, A.M., Bindels, L.B., Cambier, E., Ben-Amram, H., Koren, O., Forsythe, P., Bienenstock, J., Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior. Nat Commun 8 (2017), 1–12.
60. Buffington, S.A., Di Prisco, G.V., Auchtung, T.A., Ajami, N.J., Petrosino, J.F., Costa-Mattioli, M., Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 165 (2016), 1762–1775 Maternal high-fat diets have been linked to increased risk of disease in offspring; however, this is the first report of such diets conferring deficits to mental health. Interestingly, offspring of HF-fed dams exhibited significant reductions in cortical oxytocin receptor levels and colonization of these animals with L. reuteri was sufficient to correct this deficit.
61. Smith, C.J., Emge, J.R., Berzins, K., Lung, L., Khamishon, R., Shah, P., Rodrigues, D.M., Sousa, A.J., Reardon, C., Sherman, P.M., et al. Probiotics normalize the gut–brain–microbiota axis in immunodeficient mice. Am J Physiol: Gastrointest Liver Physiol 307 (2014), G793–G802.
62. Emge, J.R., Huynh, K., Miller, E.N., Kaur, M., Reardon, C., Barrett, K.E., Gareau, M.G., Modulation of the microbiota–gut–brain axis by probiotics in a murine model of inflammatory bowel disease. Am J Physiol: Gastrointest Liver Physiol 310 (2016), G989–G998.
63. Huang, R., Wang, K., Hu, J., Effect of probiotics on depression: a systematic review and meta-analysis of randomized controlled trials. Nutrients 8 (2016), 1–12.
64. Steenbergen, L., Sellaro, R., van Hemert, S., Bosch, J.A., Colzato, L.S., A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 48 (2015), 258–264.